Page 2 - Nasdaq Algs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aligos Therapeutics (NASDAQ:ALGS – Get Rating) and Caribou Biosciences (NASDAQ:CRBU – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk and institutional ownership. Profitability This table compares Aligos Therapeutics and Caribou Biosciences’ […]

Aligos Therapeutics (NASDAQ:ALGS – Get Rating) is scheduled to be releasing its earnings data after the market closes on Thursday, May 4th. Analysts expect Aligos Therapeutics to post earnings of ($0.47) per share for the quarter. Aligos Therapeutics (NASDAQ:ALGS – Get Rating) last issued its quarterly earnings results on Thursday, March 9th. The company reported […]

SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

SOUTH SAN FRANCISCO, Calif., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...

Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Rating) has received an average rating of “Hold” from the six analysts that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1 year price objective among brokerages that […]